{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:47:09Z","timestamp":1789012029162,"version":"build-2803163510"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T00:00:00Z","timestamp":1550102400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T00:00:00Z","timestamp":1550102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006260","name":"Rheumatology Research Foundation","doi-asserted-by":"publisher","award":["Investigator Award"],"award-info":[{"award-number":["Investigator Award"]}],"id":[{"id":"10.13039\/100006260","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006260","name":"Rheumatology Research Foundation","doi-asserted-by":"publisher","award":["Innovative Research Award"],"award-info":[{"award-number":["Innovative Research Award"]}],"id":[{"id":"10.13039\/100006260","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K08 AR073339-01"],"award-info":[{"award-number":["K08 AR073339-01"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P30 AR070253-01"],"award-info":[{"award-number":["P30 AR070253-01"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P30 AR070253-01"],"award-info":[{"award-number":["P30 AR070253-01"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01 AR065538"],"award-info":[{"award-number":["R01 AR065538"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fundacion Bechara","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Boston Children's Hospital Department of Medicine","award":["Evidence Based Guideline Program"],"award-info":[{"award-number":["Evidence Based Guideline Program"]}]},{"name":"Boston Children's Hospital Department of Medicine","award":["Evidence Based Guideline Program"],"award-info":[{"award-number":["Evidence Based Guideline Program"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12969-019-0309-6","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T09:04:33Z","timestamp":1550135073000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":97,"title":["Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome"],"prefix":"10.1186","volume":"17","author":[{"given":"Olha","family":"Halyabar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret H.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle L.","family":"Schoettler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezgi H.","family":"Baris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie A.","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Biggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Gorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mindy S.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Nigrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig D.","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory P.","family":"Priebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Sundel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj K.","family":"Surana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja G.","family":"Weinacht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny Chan","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Meleedy-Rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Starmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taruna","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Dedeoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.","family":"Degar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa M.","family":"Hazen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0242-4029","authenticated-orcid":false,"given":"Lauren A.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,14]]},"reference":[{"issue":"5","key":"309_CR1","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.hoc.2015.06.008","volume":"29","author":"B Degar","year":"2015","unstructured":"Degar B. Familial Hemophagocytic Lymphohistiocytosis. Hematol Oncol Clin North Am. 2015;29(5):903\u201313 PubMed PMID: 26461150.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"3","key":"309_CR2","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1182\/blood-2003-10-3413","volume":"104","author":"MB Jordan","year":"2004","unstructured":"Jordan MB, Hildeman D, Kappler J, Marrack P. An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. Blood. 2004;104(3):735\u201343 PubMed PMID: 15069016.","journal-title":"Blood"},{"issue":"3","key":"309_CR3","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1046\/j.1365-2249.2003.02237.x","volume":"133","author":"H Takada","year":"2003","unstructured":"Takada H, Takahata Y, Nomura A, Ohga S, Mizuno Y, Hara T. Increased serum levels of interferon-gamma-inducible protein 10 and monokine induced by gamma interferon in patients with haemophagocytic lymphohistiocytosis. Clin Exp Immunol. 2003;133(3):448\u201353 PubMed PMID: 12930373. Pubmed Central PMCID: 1808805.","journal-title":"Clin Exp Immunol"},{"key":"309_CR4","doi-asserted-by":"crossref","unstructured":"Xu XJ, Tang YM, Song H, Yang SL, Xu WQ, Zhao N, et al. Diagnostic accuracy of a specific cytokine pattern in hemophagocytic lymphohistiocytosis in children. J Pediatr. 2012;160(6):984\u201390 e1 PubMed PMID: 22226576.","DOI":"10.1016\/j.jpeds.2011.11.046"},{"issue":"2","key":"309_CR5","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124\u201331 PubMed PMID: 16937360.","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"309_CR6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/bmt.2008.232","volume":"42","author":"MB Jordan","year":"2008","unstructured":"Jordan MB, Filipovich AH. Hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis: a journey of a thousand miles begins with a single (big) step. Bone Marrow Transplant. 2008;42(7):433\u20137 PubMed PMID: 18679369.","journal-title":"Bone Marrow Transplant"},{"key":"309_CR7","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.3389\/fimmu.2017.01102","volume":"8","author":"E Brisse","year":"2017","unstructured":"Brisse E, Wouters CH, Andrei G, Matthys P. How viruses contribute to the pathogenesis of Hemophagocytic Lymphohistiocytosis. Front Immunol. 2017;8:1102 PubMed PMID: 28936212. Pubmed Central PMCID: 5594061.","journal-title":"Front Immunol"},{"issue":"19","key":"309_CR8","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1182\/blood-2015-01-551622","volume":"125","author":"AM Schram","year":"2015","unstructured":"Schram AM, Berliner N. How I treat hemophagocytic lymphohistiocytosis in the adult patient. Blood. 2015;125(19):2908\u201314 PubMed PMID: 25758828.","journal-title":"Blood"},{"key":"309_CR9","doi-asserted-by":"crossref","unstructured":"Grom AA, Horne A, De Benedetti F. Macrophage activation syndrome in the era of biologic therapy. Nat Rev Rheumatol. 2016 May;12(5):259\u201368 PubMed PMID: 27009539.","DOI":"10.1038\/nrrheum.2015.179"},{"issue":"5","key":"309_CR10","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.jpeds.2005.12.070","volume":"148","author":"T Avcin","year":"2006","unstructured":"Avcin T, Tse SM, Schneider R, Ngan B, Silverman ED. Macrophage activation syndrome as the presenting manifestation of rheumatic diseases in childhood. J Pediatr. 2006;148(5):683\u20136 PubMed PMID: 16737887.","journal-title":"J Pediatr"},{"issue":"4","key":"309_CR11","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1182\/blood-2004-08-2997","volume":"105","author":"AD Billiau","year":"2005","unstructured":"Billiau AD, Roskams T, Van Damme-Lombaerts R, Matthys P, Wouters C. Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6- and TNF-alpha-producing macrophages. Blood. 2005;105(4):1648\u201351 PubMed PMID: 15466922.","journal-title":"Blood"},{"issue":"9","key":"309_CR12","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1093\/rheumatology\/keq133","volume":"49","author":"M Shimizu","year":"2010","unstructured":"Shimizu M, Yokoyama T, Yamada K, Kaneda H, Wada H, Wada T, et al. Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis. Rheumatology (Oxford). 2010;49(9):1645\u201353 PubMed PMID: 20472718.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"309_CR13","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1136\/annrheumdis-2015-209020","volume":"76","author":"C Bracaglia","year":"2017","unstructured":"Bracaglia C, de Graaf K, Pires Marafon D, Guilhot F, Ferlin W, Prencipe G, et al. Elevated circulating levels of interferon-gamma and interferon-gamma-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Ann Rheum Dis. 2017;76(1):166\u201372 PubMed PMID: 27296321.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"309_CR14","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/art.39332","volume":"68","author":"A Ravelli","year":"2016","unstructured":"Ravelli A, Minoia F, Davi S, Horne A, Bovis F, Pistorio A, et al. 2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European league against rheumatism\/American College of Rheumatology\/Paediatric rheumatology international trials organisation collaborative initiative. Arthritis Rheumatol. 2016;68(3):566\u201376 PubMed PMID: 26314788.","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"309_CR15","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S0022-3476(96)70160-9","volume":"129","author":"R Mouy","year":"1996","unstructured":"Mouy R, Stephan JL, Pillet P, Haddad E, Hubert P, Prieur AM. Efficacy of cyclosporine a in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases. J Pediatr. 1996;129(5):750\u20134 PubMed PMID: 8917244.","journal-title":"J Pediatr"},{"issue":"11","key":"309_CR16","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1093\/rheumatology\/40.11.1285","volume":"40","author":"JL Stephan","year":"2001","unstructured":"Stephan JL, Kone-Paut I, Galambrun C, Mouy R, Bader-Meunier B, Prieur AM. Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology. 2001;40(11):1285\u201392 PubMed PMID: 11709613.","journal-title":"Rheumatology"},{"issue":"2","key":"309_CR17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0022-3476(96)70408-0","volume":"128","author":"A Ravelli","year":"1996","unstructured":"Ravelli A, De Benedetti F, Viola S, Martini A. Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine. J Pediatr. 1996;128(2):275\u20138 PubMed PMID: 8636829.","journal-title":"J Pediatr"},{"issue":"2","key":"309_CR18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/rheumatology\/keq218","volume":"50","author":"PM Miettunen","year":"2011","unstructured":"Miettunen PM, Narendran A, Jayanthan A, Behrens EM, Cron RQ. Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients. Rheumatology (Oxford). 2011;50(2):417\u20139 PubMed PMID: 20693540.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"309_CR19","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3899\/jrheum.091046","volume":"37","author":"M Durand","year":"2010","unstructured":"Durand M, Troyanov Y, Laflamme P, Gregoire G. Macrophage activation syndrome treated with anakinra. J Rheumatol. 2010;37(4):879\u201380 PubMed PMID: 20360206.","journal-title":"J Rheumatol"},{"issue":"1","key":"309_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/RHU.0b013e318205092d","volume":"17","author":"N Bruck","year":"2011","unstructured":"Bruck N, Suttorp M, Kabus M, Heubner G, Gahr M, Pessler F. Rapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroids. J Clin Rheumatol. 2011;17(1):23\u20137 PubMed PMID: 21169853.","journal-title":"J Clin Rheumatol"},{"issue":"22","key":"309_CR21","doi-asserted-by":"publisher","first-page":"5794","DOI":"10.1182\/blood-2011-07-370148","volume":"118","author":"K Zhang","year":"2011","unstructured":"Zhang K, Jordan MB, Marsh RA, Johnson JA, Kissell D, Meller J, et al. Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH. Blood. 2011;118(22):5794\u20138 PubMed PMID: 21881043. Pubmed Central PMCID: 3228496.","journal-title":"Blood"},{"issue":"7","key":"309_CR22","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/infdis\/jiv550","volume":"213","author":"GS Schulert","year":"2016","unstructured":"Schulert GS, Zhang M, Fall N, Husami A, Kissell D, Hanosh A, et al. Whole-exome sequencing reveals mutations in genes linked to Hemophagocytic Lymphohistiocytosis and macrophage activation syndrome in fatal cases of H1N1 influenza. J Infect Dis. 2016;213(7):1180\u20138 PubMed PMID: 26597256. Pubmed Central PMCID: 4779301.","journal-title":"J Infect Dis"},{"issue":"12","key":"309_CR23","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1002\/art.38793","volume":"66","author":"KM Kaufman","year":"2014","unstructured":"Kaufman KM, Linghu B, Szustakowski JD, Husami A, Yang F, Zhang K, et al. Whole-exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis. Arthritis Rheumatol. 2014;66(12):3486\u201395 PubMed PMID: 25047945. Pubmed Central PMCID: 4321811.","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"309_CR24","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1067\/mpd.2003.110","volume":"142","author":"AA Grom","year":"2003","unstructured":"Grom AA, Villanueva J, Lee S, Goldmuntz EA, Passo MH, Filipovich A. Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome. J Pediatr. 2003;142(3):292\u20136 PubMed PMID: 12640378.","journal-title":"J Pediatr"},{"issue":"11","key":"309_CR25","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1002\/art.39295","volume":"67","author":"L Cifaldi","year":"2015","unstructured":"Cifaldi L, Prencipe G, Caiello I, Bracaglia C, Locatelli F, De Benedetti F, et al. Inhibition of natural killer cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome. Arthritis Rheumatol. 2015;67(11):3037\u201346 PubMed PMID: 26251193.","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"309_CR26","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/ng.3089","volume":"46","author":"SW Canna","year":"2014","unstructured":"Canna SW, de Jesus AA, Gouni S, Brooks SR, Marrero B, Liu Y, et al. An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Nat Genet. 2014;46(10):1140\u20136 PubMed PMID: 25217959. Pubmed Central PMCID: 4177369.","journal-title":"Nat Genet"},{"issue":"1","key":"309_CR27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.cyto.2013.09.007","volume":"65","author":"T Wada","year":"2014","unstructured":"Wada T, Kanegane H, Ohta K, Katoh F, Imamura T, Nakazawa Y, et al. Sustained elevation of serum interleukin-18 and its association with hemophagocytic lymphohistiocytosis in XIAP deficiency. Cytokine. 2014;65(1):74\u20138 PubMed PMID: 24084330.","journal-title":"Cytokine"},{"issue":"1","key":"309_CR28","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1046\/j.1365-2141.1999.01504.x","volume":"106","author":"H Takada","year":"1999","unstructured":"Takada H, Ohga S, Mizuno Y, Suminoe A, Matsuzaki A, Ihara K, et al. Oversecretion of IL-18 in haemophagocytic lymphohistiocytosis: a novel marker of disease activity. Br J Haematol. 1999;106(1):182\u20139 PubMed PMID: 10444185.","journal-title":"Br J Haematol"},{"issue":"13","key":"309_CR29","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1182\/blood-2017-12-820852","volume":"131","author":"ES Weiss","year":"2018","unstructured":"Weiss ES, Girard-Guyonvarc'h C, Holzinger D, de Jesus AA, Tariq Z, Picarsic J, et al. Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome. Blood. 2018;131(13):1442\u201355 PubMed PMID: 29326099. Pubmed Central PMCID: 5877443.","journal-title":"Blood"},{"issue":"6552","key":"309_CR30","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/378088a0","volume":"378","author":"H Okamura","year":"1995","unstructured":"Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature. 1995;378(6552):88\u201391 PubMed PMID: 7477296.","journal-title":"Nature"},{"issue":"23","key":"309_CR31","doi-asserted-by":"crossref","first-page":"LBA-3","DOI":"10.1182\/blood.V126.23.LBA-3.LBA-3","volume":"126","author":"MB Jordan","year":"2015","unstructured":"Jordan MB, Locatelli F, Allen C, De Benedetti F, Grom AA, Ballabio M, Ferlin G, Nl-0501-04 Study Group, De Min C. A Novel Targeted Approach to the Treatment of Hemophagocytic Lymphohistiocytosis (HLH) with an Anti-Interferon Gamma (IFN\u03b3) Monoclonal Antibody (mAb), NI-0501: First Results from a Pilot Phase 2 Study in Children with Primary HLH. Blood. 2015;126(23):LBA-3.","journal-title":"Blood"},{"issue":"8","key":"309_CR32","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1093\/rheumatology\/keu524","volume":"54","author":"K Put","year":"2015","unstructured":"Put K, Avau A, Brisse E, Mitera T, Put S, Proost P, et al. Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-gamma. Rheumatology. 2015;54(8):1507\u201317 PubMed PMID: 25767156.","journal-title":"Rheumatology"},{"issue":"2","key":"309_CR33","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1136\/emermed-2014-204363","volume":"33","author":"AT Akenroye","year":"2016","unstructured":"Akenroye AT, Stack AM. The development and evaluation of an evidence-based guideline programme to improve care in a paediatric emergency department. Emerg Med J. 2016;33(2):109\u201317 PubMed PMID: 26150121.","journal-title":"Emerg Med J"},{"issue":"10","key":"309_CR34","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1002\/art.38769","volume":"66","author":"S Davi","year":"2014","unstructured":"Davi S, Minoia F, Pistorio A, Horne A, Consolaro A, Rosina S, et al. Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Arthritis Rheumatol. 2014;66(10):2871\u201380 PubMed PMID: 25044674.","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"309_CR35","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1002\/pbc.25058","volume":"61","author":"K Lehmberg","year":"2014","unstructured":"Lehmberg K, McClain KL, Janka GE, Allen CE. Determination of an appropriate cut-off value for ferritin in the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2014;61(11):2101\u20133 PubMed PMID: 24753034.","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"309_CR36","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/pbc.21423","volume":"50","author":"CE Allen","year":"2008","unstructured":"Allen CE, Yu X, Kozinetz CA, McClain KL. Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2008;50(6):1227\u201335 PubMed PMID: 18085676.","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"309_CR37","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s12185-015-1813-1","volume":"102","author":"H Saeed","year":"2015","unstructured":"Saeed H, Woods RR, Lester J, Herzig R, Gul Z, Monohan G. Evaluating the optimal serum ferritin level to identify hemophagocytic lymphohistiocytosis in the critical care setting. Int J Hematol. 2015;102(2):195\u20139 PubMed PMID: 25997871.","journal-title":"Int J Hematol"},{"issue":"10","key":"309_CR38","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1182\/blood-2014-10-602607","volume":"125","author":"AM Schram","year":"2015","unstructured":"Schram AM, Campigotto F, Mullally A, Fogerty A, Massarotti E, Neuberg D, et al. Marked hyperferritinemia does not predict for HLH in the adult population. Blood. 2015;125(10):1548\u201352 PubMed PMID: 25573993.","journal-title":"Blood"},{"issue":"4","key":"309_CR39","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.semarthrit.2014.09.004","volume":"44","author":"MM Kostik","year":"2015","unstructured":"Kostik MM, Dubko MF, Masalova VV, Snegireva LS, Kornishina TL, Chikova IA, et al. Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis. Semin Arthritis Rheum. 2015;44(4):417\u201322 PubMed PMID: 25300700.","journal-title":"Semin Arthritis Rheum"},{"issue":"Supp1","key":"309_CR40","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1546-0096-12-S1-P53","volume":"12","author":"CSE Bracaglia","year":"2014","unstructured":"Bracaglia CSE, Da Ros M, De Fusco C, Micalizzi M, Cetica V, Ciambotti B, Coniglio ML, Insalaco A, De Benedetti F, Arico M. Mutations of familial hemophagocytic lymphohistiocytosis (FHL) related genes and abnormalities of cytotoxicity function tests in patients with macrophage activation syndrome (MAS) occuring in systemic juvenile idiopathic arthritis (sJIA). Pediatr Rheumatol Online J. 2014;12(Supp1):53.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"6","key":"309_CR41","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1172\/JCI43157","volume":"121","author":"EM Behrens","year":"2011","unstructured":"Behrens EM, Canna SW, Slade K, Rao S, Kreiger PA, Paessler M, et al. Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice. J Clin Invest. 2011;121(6):2264\u201377 PubMed PMID: 21576823. Pubmed Central PMCID: 3104738.","journal-title":"J Clin Invest"},{"key":"309_CR42","doi-asserted-by":"crossref","unstructured":"Prencipe G, Caiello I, Pascarella A, Grom AA, Bracaglia C, Chatel L, et al. Neutralization of IFN-gamma reverts clinical and laboratory features in a mouse model of macrophage activation syndrome. J Allergy Clin Immunol. 2018 Apr;141(4):1439\u201349 PubMed PMID: 28807602.","DOI":"10.1016\/j.jaci.2017.07.021"},{"issue":"13","key":"309_CR43","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1182\/blood-2017-06-789552","volume":"131","author":"C Girard-Guyonvarc'h","year":"2018","unstructured":"Girard-Guyonvarc'h C, Palomo J, Martin P, Rodriguez E, Troccaz S, Palmer G, et al. Unopposed IL-18 signaling leads to severe TLR9-induced macrophage activation syndrome in mice. Blood. 2018;131(13):1430\u201341 PubMed PMID: 29295842.","journal-title":"Blood"},{"issue":"5","key":"309_CR44","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/j.jaci.2016.10.022","volume":"139","author":"SW Canna","year":"2017","unstructured":"Canna SW, Girard C, Malle L, de Jesus A, Romberg N, Kelsen J, et al. Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition. J Allergy Clin Immunol. 2017;139(5):1698\u2013701 PubMed PMID: 27876626. Pubmed Central PMCID: 5846100.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"309_CR45","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/bjh.13462","volume":"170","author":"K Lehmberg","year":"2015","unstructured":"Lehmberg K, Sprekels B, Nichols KE, Woessmann W, Muller I, Suttorp M, et al. Malignancy-associated haemophagocytic lymphohistiocytosis in children and adolescents. Br J Haematol. 2015;170(4):539\u201349 PubMed PMID: 25940575.","journal-title":"Br J Haematol"},{"issue":"1","key":"309_CR46","doi-asserted-by":"publisher","first-page":"e000161","DOI":"10.1136\/rmdopen-2015-000161","volume":"2","author":"A Ravelli","year":"2016","unstructured":"Ravelli A, Minoia F, Davi S, Horne A, Bovis F, Pistorio A, et al. Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. RMD open. 2016;2(1):e000161 PubMed PMID: 26848401. Pubmed Central PMCID: 4731834.","journal-title":"RMD open"},{"issue":"7","key":"309_CR47","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1007\/s10875-017-0439-x","volume":"37","author":"B Kumar","year":"2017","unstructured":"Kumar B, Aleem S, Saleh H, Petts J, Ballas ZK. A personalized diagnostic and treatment approach for macrophage activation syndrome and secondary Hemophagocytic Lymphohistiocytosis in adults. J Clin Immunol. 2017;37(7):638\u201343 PubMed PMID: 28871523.","journal-title":"J Clin Immunol"},{"issue":"5","key":"309_CR48","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/PCC.0000000000000078","volume":"15","author":"S Rajasekaran","year":"2014","unstructured":"Rajasekaran S, Kruse K, Kovey K, Davis AT, Hassan NE, Ndika AN, et al. Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis\/sepsis\/multiple organ dysfunction\/macrophage activating syndrome in critically ill children*. Pediatr Crit Care Med. 2014;15(5):401\u20138 PubMed PMID: 24583503.","journal-title":"Pediatr Crit Care Med"},{"key":"309_CR49","first-page":"885066617711386","volume":"1","author":"P Wohlfarth","year":"2017","unstructured":"Wohlfarth P, Agis H, Gualdoni GA, Weber J, Staudinger T, Schellongowski P, et al. Interleukin 1 receptor antagonist Anakinra, intravenous immunoglobulin, and corticosteroids in the Management of Critically ill Adult Patients with Hemophagocytic Lymphohistiocytosis. J Intensive Care Med. 2017;1:885066617711386 PubMed PMID: 28631531.","journal-title":"J Intensive Care Med"},{"issue":"4","key":"309_CR50","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3899\/jrheum.140288","volume":"42","author":"S Yokota","year":"2015","unstructured":"Yokota S, Itoh Y, Morio T, Sumitomo N, Daimaru K, Minota S. Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis under treatment with tocilizumab. J Rheumatol. 2015;42(4):712\u201322 PubMed PMID: 25684767.","journal-title":"J Rheumatol"},{"issue":"2","key":"309_CR51","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.cyto.2012.02.006","volume":"58","author":"M Shimizu","year":"2012","unstructured":"Shimizu M, Nakagishi Y, Kasai K, Yamasaki Y, Miyoshi M, Takei S, et al. Tocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: the diagnostic significance of interleukin-18 and interleukin-6. Cytokine. 2012;58(2):287\u201394 PubMed PMID: 22398373.","journal-title":"Cytokine"},{"key":"309_CR52","doi-asserted-by":"publisher","first-page":"5656320","DOI":"10.1155\/2016\/5656320","volume":"2016","author":"E Watanabe","year":"2016","unstructured":"Watanabe E, Sugawara H, Yamashita T, Ishii A, Oda A, Terai C. Successful tocilizumab therapy for macrophage activation syndrome associated with adult-onset Still's disease: a case-based review. Case Rep Med. 2016;2016:5656320 PubMed PMID: 27688774. Pubmed Central PMCID: 5027298.","journal-title":"Case Rep Med"},{"issue":"7","key":"309_CR53","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1093\/rheumatology\/keu019","volume":"53","author":"E Savage","year":"2014","unstructured":"Savage E, Wazir T, Drake M, Cuthbert R, Wright G. Fulminant myocarditis and macrophage activation syndrome secondary to adult-onset Still's disease successfully treated with tocilizumab. Rheumatology. 2014;53(7):1352\u20133. PubMed PMID: 24609056.","journal-title":"Rheumatology"},{"issue":"16","key":"309_CR54","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","volume":"371","author":"SL Maude","year":"2014","unstructured":"Maude SL, Frey N, Shaw PA, Aplenc R, Barrett DM, Bunin NJ, et al. Chimeric antigen receptor T cells for sustained remissions in leukemia. N Engl J Med. 2014;371(16):1507\u201317 PubMed PMID: 25317870. Pubmed Central PMCID: 4267531.","journal-title":"N Engl J Med"},{"issue":"26","key":"309_CR55","doi-asserted-by":"publisher","first-page":"5154","DOI":"10.1182\/blood-2013-02-485623","volume":"121","author":"DT Teachey","year":"2013","unstructured":"Teachey DT, Rheingold SR, Maude SL, Zugmaier G, Barrett DM, Seif AE, et al. Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy. Blood. 2013;121(26):5154\u20137 PubMed PMID: 23678006. Pubmed Central PMCID: 4123427.","journal-title":"Blood"},{"issue":"3","key":"309_CR56","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/acr.23277","volume":"70","author":"GS Schulert","year":"2018","unstructured":"Schulert GS, Minoia F, Bohnsack J, Cron RQ, Hashad S, Kon EPI, et al. Effect of biologic therapy on clinical and laboratory features of macrophage activation syndrome associated with systemic juvenile idiopathic arthritis. Arthritis care & research. 2018;70(3):409\u201319 PubMed PMID: 28499329.","journal-title":"Arthritis care & research"},{"issue":"6","key":"309_CR57","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.semarthrit.2015.11.002","volume":"45","author":"A Lenert","year":"2016","unstructured":"Lenert A, Yao Q. Macrophage activation syndrome complicating adult onset Still's disease: a single center case series and comparison with literature. Semin Arthritis Rheum. 2016;45(6):711\u20136 PubMed PMID: 26672682.","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"309_CR58","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","volume":"44","author":"B Shakoory","year":"2016","unstructured":"Shakoory B, Carcillo JA, Chatham WW, Amdur RL, Zhao H, Dinarello CA, et al. Interleukin-1 receptor blockade is associated with reduced mortality in Sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial. Crit Care Med. 2016;44(2):275\u201381 PubMed PMID: 26584195. Pubmed Central PMCID: 5378312.","journal-title":"Crit Care Med"},{"issue":"5","key":"309_CR59","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3899\/jrheum.121098","volume":"40","author":"PJ Kahn","year":"2013","unstructured":"Kahn PJ, Cron RQ. Higher-dose Anakinra is effective in a case of medically refractory macrophage activation syndrome. J Rheumatol. 2013;40(5):743\u20134 PubMed PMID: 23637382.","journal-title":"J Rheumatol"},{"issue":"2","key":"309_CR60","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.semarthrit.2010.12.001","volume":"41","author":"R Nair","year":"2011","unstructured":"Nair R, Aggarwal R, Khanna D. Methods of formal consensus in classification\/diagnostic criteria and guideline development. Semin Arthritis Rheum. 2011;41(2):95\u2013105 PubMed PMID: 21420149. Pubmed Central PMCID: 3131416.","journal-title":"Semin Arthritis Rheum"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-019-0309-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12969-019-0309-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-019-0309-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T05:43:24Z","timestamp":1589521404000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-019-0309-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,14]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["309"],"URL":"https:\/\/doi.org\/10.1186\/s12969-019-0309-6","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,14]]},"assertion":[{"value":"2 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Institutional Review Board (IRB) approval was not obtained as this is QI-related research and the EBG process is exempt from IRB review at Boston Children\u2019s Hospital.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"7"}}